Fig 3. Biodosimetry model for using Point of Care and High Throughput Screening Systems for medical triage after an IND detonation.

After the event it is anticipated that one million people could require biodosimetry screening to determine their dose of exposure to radiation. A point of care device with the use profile shown in Table 2 is preferred for the initial triage. After the first round of biodosimetry, it is anticipated that the number of people requiring additional testing will be reduced to around 400,000. More complex methods can then be used on this smaller population to refine initial dose estimates, with a high-throughput system being preferred.